Astellas Pharma Inc. (TYO:4503)
Japan
· Delayed Price · Currency is JPY 2,414.00
+44.00 (1.86%)
Mar 10, 2026, 12:35 PM JST
Astellas Pharma Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,245,182 | 2,589,390 | 2,946,773 | 3,381,409 | 3,519,738 | 3,161,421 | Upgrade
|
| Market Cap Growth | 63.21% | -12.13% | -12.85% | -3.93% | 11.33% | 1.80% | Upgrade
|
| Enterprise Value | 4,717,906 | 3,324,889 | 3,565,926 | 3,003,971 | 3,170,189 | 2,856,153 | Upgrade
|
| Last Close Price | 2370.00 | 1412.19 | 1531.31 | 1690.42 | 1661.58 | 1441.59 | Upgrade
|
| PE Ratio | 13.23 | 51.03 | 172.88 | 34.26 | 28.37 | 26.22 | Upgrade
|
| Forward PE | 15.40 | 18.73 | 21.06 | 15.87 | 16.50 | 15.21 | Upgrade
|
| PS Ratio | 2.06 | 1.35 | 1.84 | 2.23 | 2.72 | 2.53 | Upgrade
|
| PB Ratio | 2.41 | 1.71 | 1.85 | 2.24 | 2.41 | 2.28 | Upgrade
|
| P/TBV Ratio | 15.44 | - | - | 5.48 | 6.59 | 7.02 | Upgrade
|
| P/FCF Ratio | 10.43 | 16.44 | 21.92 | 11.61 | 15.53 | 11.48 | Upgrade
|
| P/OCF Ratio | 9.27 | 13.31 | 17.09 | 10.32 | 13.67 | 10.30 | Upgrade
|
| PEG Ratio | 0.26 | 0.17 | 1.48 | 0.68 | 0.70 | 2.26 | Upgrade
|
| EV/Sales Ratio | 2.29 | 1.74 | 2.22 | 1.98 | 2.45 | 2.29 | Upgrade
|
| EV/EBITDA Ratio | 7.77 | 7.19 | 12.63 | 8.90 | 10.64 | 8.83 | Upgrade
|
| EV/EBIT Ratio | 11.36 | 12.62 | 28.62 | 12.97 | 14.53 | 11.38 | Upgrade
|
| EV/FCF Ratio | 11.59 | 21.11 | 26.53 | 10.31 | 13.98 | 10.37 | Upgrade
|
| Debt / Equity Ratio | 0.41 | 0.62 | 0.63 | 0.14 | 0.15 | 0.20 | Upgrade
|
| Debt / EBITDA Ratio | 1.19 | 2.03 | 3.57 | 0.61 | 0.72 | 0.86 | Upgrade
|
| Debt / FCF Ratio | 1.78 | 5.95 | 7.50 | 0.70 | 0.94 | 1.01 | Upgrade
|
| Net Debt / Equity Ratio | 0.27 | 0.50 | 0.42 | -0.11 | -0.07 | -0.03 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.77 | 1.62 | 2.38 | -0.51 | -0.34 | -0.15 | Upgrade
|
| Net Debt / FCF Ratio | 1.16 | 4.75 | 5.00 | -0.59 | -0.45 | -0.17 | Upgrade
|
| Asset Turnover | 0.58 | 0.55 | 0.53 | 0.63 | 0.56 | 0.54 | Upgrade
|
| Inventory Turnover | 1.27 | 1.28 | 1.38 | 1.76 | 1.60 | 1.56 | Upgrade
|
| Quick Ratio | 0.79 | 0.79 | 0.69 | 1.13 | 1.05 | 1.15 | Upgrade
|
| Current Ratio | 1.09 | 1.13 | 0.93 | 1.45 | 1.34 | 1.47 | Upgrade
|
| Return on Equity (ROE) | 19.81% | 3.26% | 1.10% | 6.65% | 8.72% | 9.01% | Upgrade
|
| Return on Assets (ROA) | 7.38% | 4.77% | 2.58% | 6.05% | 5.92% | 6.83% | Upgrade
|
| Return on Invested Capital (ROIC) | 16.07% | 11.63% | 4.72% | 12.83% | 12.80% | 15.28% | Upgrade
|
| Return on Capital Employed (ROCE) | 18.30% | 11.60% | 5.50% | 13.40% | 13.30% | 14.90% | Upgrade
|
| Earnings Yield | 7.61% | 1.96% | 0.58% | 2.92% | 3.52% | 3.81% | Upgrade
|
| FCF Yield | 9.59% | 6.08% | 4.56% | 8.62% | 6.44% | 8.71% | Upgrade
|
| Dividend Yield | 3.24% | 5.24% | 4.57% | 3.55% | 3.01% | 2.91% | Upgrade
|
| Payout Ratio | 42.15% | 254.19% | 684.38% | 101.66% | 68.69% | 63.15% | Upgrade
|
| Buyback Yield / Dilution | -0.64% | 0.14% | 1.39% | 1.38% | 0.41% | 1.03% | Upgrade
|
| Total Shareholder Return | 2.61% | 5.38% | 5.96% | 4.93% | 3.42% | 3.94% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.